J&J files U.S. application for MS med ponesimod [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
Healthcare J&J files U.S. application for MS med ponesimod Mar. 18, 2020 4:06 PM ET | Johnson & Johnson (JNJ) Douglas W. House Johnson & Johnson (NYSE: marketing application MS is a chronic autoimmune inflammatory disorder of the central nervous system (CNS). Ponesimod modulates a protein called sphingosine-1-phosphate receptor 1 (S1P1) that reduces the number of circulating lymphocytes by trapping them in the lymph nodes which reduces the number of the pro-inflammatory cells that can cross into the CNS thereby dampening inflammation. Click to subscribe to real-time analytics on JNJ Now read: Johnson & Johnson Remicade Biosim Setback, And Other News: The Good, Bad And Ugly Of Biopharma »
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Justice Department is investigating McKinsey consulting firm's role in opioid epidemic [CNN]CNN
- BioNJ Announces Lineup for BioPartnering Conference [Yahoo! Finance]Yahoo! Finance
- CURE Media Group and Oncology Nursing News® announce Meaghan Mooney, B.S.N., RN, OCN, as the winner of the 2024 Extraordinary Healer® Award [Yahoo! Finance]Yahoo! Finance
- Global Pharmaceutical Drug Delivery Research Report 2024: $2.07 Billion Oral, Injectable, Transdermal, Inhalable, and Implantable Devices Size, Share, Trends, Opportunities and Forecasts, 2019-2029F [Yahoo! Finance]Yahoo! Finance
- Envisagenics Validates AI/ML Approach for RNA Target Identification and SSO Therapeutic Development [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website